Church & Dwight Co. (CHD)
(Delayed Data from NYSE)
$102.16 USD
-0.48 (-0.47%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $102.11 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$102.16 USD
-0.48 (-0.47%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $102.11 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Church & Dwight (CHD) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 11.63% and 0.79%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for International Flavors' (IFF) Q1 Earnings?
by Zacks Equity Research
International Flavors' (IFF) Q1 results are likely to reflect the impacts of lower volumes and escalating costs.
Will Energy Drinks Aid Monster Beverage's (MNST) Q1 Earnings?
by Zacks Equity Research
Monster Beverage (MNST) Q1 results are expected to reflect continued positive trends in the energy drinks category amid rising commodity costs and inflation.
How to Play Hershey (HSY) Ahead of Q1 Earnings Release?
by Zacks Equity Research
Hershey's (HSY) strong brands and pricing leverage position it well for Q1 earnings, though cost inflation is a concern.
Central Garden & Pet Company (CENT) Queued for Q2 Earnings
by Zacks Equity Research
Central Garden & Pet (CENT) faces challenges from deflation, changing consumer behavior and softer pet adoptions. However, the Garden segment is likely to showcase strength.
Kellanova (K) Not Too Palatable Before Q1 Earnings: How to Play?
by Vrishali Bagree
Kellanova's (K) slowing growth in certain categories, rising elasticities and a challenging operating landscape raise concerns ahead of first-quarter earnings, though brand strength is an upside.
How to Play Kraft Heinz (KHC) Ahead of Q1 Earnings Release?
by Zacks Equity Research
As investors weigh the prospects of Kraft Heinz (KHC) ahead of its Q1 earnings release, the company faces several challenges like inflationary pressures, soft volumes and currency headwinds.
What Awaits for Service Corporation's (SCI) Q4 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) first-quarter 2024 performance will likely reflect the adverse impact of moderation in consumer discretionary spending amid the rising interest rate environment.
Is Coca-Cola (KO) a Good Buy Option Just Before Q1 Earnings?
by Zacks Equity Research
Coca-Cola's (KO) market position, innovation and digital growth initiatives, along with solid business momentum, supported by robust consumer demand, place it well ahead of Q1 earnings.
Here's How Clorox (CLX) is Placed Ahead of Q3 Earnings Release
by Zacks Equity Research
Clorox (CLX) third-quarter results are likely to reflect challenges related to continued impacts of the recent cyberattack incident, inflationary costs and elevated SG&A expense.
Pilgrim's Pride (PPC) Queues for Q1 Earnings: What's in Store?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q1 performance will likely reflect gains from strategic business integrations and customer relationships. A focus on key customers and supply-chain improvements bodes well.
What Awaits The Estee Lauder Companies (EL) in Q3 Earnings?
by Zacks Equity Research
The Estee Lauder Companies' (EL) third-quarter performance will likely reflect strong growth across various emerging markets. However, unfavorable currency headwinds are a threat.
Gear Up for Church & Dwight (CHD) Q1 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Church & Dwight (CHD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Mondelez (MDLZ) Gears Up for Q1 Earnings: What to Expect?
by Zacks Equity Research
Mondelez's (MDLZ) first-quarter results are likely to reflect strength in core categories like chocolates and biscuits, while cost inflation and volatile consumer behavior are a concern.
Investing in Sysco (SYY) Ahead of Q3 Earnings: Risks & Rewards
by Zacks Equity Research
Sysco's (SYY) extensive product range, proficiency of the sales team and strength of the supply chain position it well for Q3 earnings, though product cost inflation is a concern.
Here's How Archer Daniels (ADM) is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Archer Daniels' (ADM) first-quarter 2024 results are likely to reflect the adverse impacts of higher costs and inflation. It has been witnessing a soft Nutrition segment for a while.
Church & Dwight (CHD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Newell (NWL) is Placed Just Ahead of Q1 Earnings
by Zacks Equity Research
Newell's (NWL) first-quarter 2024 performance is likely to have been hurt by a challenging macroeconomic environment and elevated levels of inflation.
Here's How Colgate (CL) Stock is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Colgate's (CL) first-quarter 2024 performance is likely to gain from solid consumer demand and efforts related to innovation, premiumization and digital transformation.
Colgate (CL) to Retain Earnings Momentum in Q1: Wise to Buy?
by Zacks Equity Research
Colgate's (CL) aggressive pricing actions, along with solid business momentum, supported by robust consumer demand and innovation, should craft its successful earnings story.
Should You Buy Altria (MO) Ahead of Q1 Earnings Release?
by Zacks Equity Research
Despite facing several challenges, we maintain our belief in Altria's (MO) strong fundamentals and its potential for growth.
Helen of Troy (HELE) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Helen of Troy's (HELE) fourth-quarter performance is likely to reflect the adverse impact of pressured consumer spending. Persistent inflationary headwinds are a concern.
Keurig Dr Pepper's (KDP) Q1 Earnings Coming Up: What's in Store?
by Zacks Equity Research
Keurig Dr Pepper's (KDP) first-quarter 2024 results are likely to reflect gains from brand strength, significant pricing actions and a solid performance in its cold beverages.
Procter & Gamble (PG) Q3 Earnings Top Estimates, Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results gain from sales growth across operating segments, improved organic sales and margin expansion, offset by higher SG&A expenses.
Can Boston Beer (SAM) Beat on Q1 Earnings Despite Cost Woes?
by Zacks Equity Research
Boston Beer's (SAM) Q1 results are expected to reflect gains from its focus on pricing, product innovation, growth of non-beer categories and brand development.